Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 11,000 | 0 | 0 | 0 | 0 |
| Gross Profit | 11,000 | N/A | N/A | N/A | N/A |
| Operating Expenses | 22,270 | 21,972 | 24,457 | 28,536 | 35,020 |
| Operating Income | -11,270 | -21,972 | -24,457 | -28,536 | -35,020 |
| Other Income | 684 | 900 | 1,223 | 1,611 | 1,695 |
| Pre-tax Income | -10,586 | -21,072 | -23,234 | -26,925 | -33,325 |
| Net Income Continuous | -10,586 | -21,072 | -23,234 | -26,925 | -33,325 |
| Net Income | $-10,586 | $-21,072 | $-23,234 | $-26,925 | $-33,325 |
| EPS Basic Total Ops | -0.22 | -0.44 | -0.48 | -0.55 | -0.70 |
| EPS Basic Continuous Ops | -0.22 | -0.44 | -0.48 | -0.56 | -0.70 |
| EPS Diluted Total Ops | -0.22 | -0.44 | -0.48 | -0.55 | -0.70 |
| EPS Diluted Continuous Ops | -0.22 | -0.44 | -0.48 | -0.56 | -0.70 |
| EPS Diluted Before Non-Recurring Items | -0.22 | -0.44 | -0.48 | -0.56 | -0.70 |
| EBITDA(a) | $-11,042 | $-21,743 | $-24,217 | $-28,168 | $-34,750 |